US$ 29.64
semaglutide for type 2 diabetes (Ozempic/Wegovy) shows 3-year efficacy blood sugar control and weight loss Semaglutide ⏺Type 2 diabetes mellitus
Description
Not every patient qualifies for Ozempic, Wegovy, or semaglutide treatment
5) History of pancreatitis (in some cases)

If you are breastfeeding , discuss the risks and benefits with your provider, as data on GLP-1 receptor agonists during lactation is limited

J Clin Endocrinol Metab (2002) 87(3):123946
Leaving the vial on a counter or in a warm room for extended periods accelerates peptide degradation

This was followed by Liraglutide from Novo Nordisk, approved in June 2009
